1 recruiting. 1 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Recruiting 1 |
Follow Incuron: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of CBL0137 in Combination With Ipilimumab and Nivolumab Therapy in Melanoma CBL0137, Ipilimumab, Nivolumab - Locally Advanced or Metastatic Melanoma | Early Phase 1 | Recruiting | Fox Chase Cancer Center | 12 | 2022-11-30 | 2026-05-22 |
Melanoma (1)
CBLC137 (1) · Ipilimumab (1) · Nivolumab (1)
United States (1)